Last update 16 Jul 2025

PANK-003

Overview

Basic Info

Drug Type
Natural Killer Cell Therapies
Synonyms
PANK Therapy(Guangdong Xiankangda Biotechnology), Peripheral Blood Mononuclear cell (PBMC) Derived Allogeneic Natural killler (NK) cell
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsRespiratory DiseasesDigestive System Disorders
Active Indication
Non-small cell lung cancer stage IIIASolid tumorHepatocellular Carcinoma
Inactive Indication-
Originator Organization
Guangdong Xiankangda Biotechnology Co. Ltd.
Active Organization
Shenzhen Celconta Life Science Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

2
Clinical Trials associated with PANK-003
NCT07043907
/ Not yet recruitingPhase 2
A Single-center, Single-arm Exploratory Clinical Trial on the Safety and Efficacy of PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA Non-Small Cell Lung Cancer
NCT06897228
/ RecruitingPhase 1
A Single-center, Single-arm, Dose-escalation Exploratory Clinical Trial on the Safety and Efficacy of PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors
100 Clinical Results associated with PANK-003
Login to view more data
100 Translational Medicine associated with PANK-003
Login to view more data
100 Patents (Medical) associated with PANK-003
Login to view more data
100 Deals associated with PANK-003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-small cell lung cancer stage IIIAPhase 2-
Shenzhen Celconta Life Science Co., Ltd.
08 Jul 2025
Solid tumorPhase 1
China
Shenzhen Celconta Life Science Co., Ltd.
18 Feb 2024
Hepatocellular CarcinomaPreclinical
United States
Shenzhen Celconta Life Science Co., Ltd.
15 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free